| |
| Issue |
Title |
| |
| No 4 (2020) |
Implementation of anti-epidemic measures, caused by COVID-19 pandemia, in TB-faci lity with inpatient clinic |
Abstract
PDF (Rus)
|
|
G. S. Oganesova |
| |
| No 1 (2017) |
Клинические рекомендации по диагностике латентной туберкулезной инфекции и химиопрофилактике заболевания в группах риска у взрослых |
Abstract
PDF (Rus)
|
|
|
| |
| No 3 (2017) |
Psychological profile of primary school age children with various manifestations of tuberculosis infection |
Abstract
PDF (Rus)
|
|
E. V. Martusova |
| |
| No 4 (2017) |
Combined anti-tuberculosis drugs as a world trend treatment for children with tuberculosis |
Abstract
PDF (Rus)
|
|
N. I. Klevno, V. A. Aksenova, A. D. Pakhlavonova, A. V. Kazakov |
| |
| No 4 (2016) |
The disinfection activities in health care facilities in the event of tuberculosis |
Abstract
PDF (Rus)
|
|
I. V. Nozdrevatyh, A. V. Gorbunov |
| |
| No 1 (2015) |
The regimens of TB patients chemotherapy creation based on contemporary regulatory acts |
Abstract
PDF (Rus)
|
|
Yu. Yu. Garmash, S. E. Borisov |
| |
| No 3 (2014) |
PERIPHERAL NEUROPATHY COMPLICATING ANTI-TUBERCULOSIS TREATMENT |
Abstract
PDF (Rus)
|
|
D. A. Ivanova, Zh. Kh. Zarudy, T. I. Ivanova |
| |
| No 4 (2014) |
HAEMATOLOGICAL COMPLICATIONS OF ANTI-TUBERCULOSIS CHEMOTHERAPY |
Abstract
PDF (Rus)
|
|
D. A. Ivanova |
| |
| No 2 (2013) |
MOLECULAR MECHANISMS UNDERLYING EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, AND ASSAYS AVAILABLE FOR ITS DETECTION |
Abstract
PDF (Rus)
|
|
E. Yu. Nosova, M. B. Gikalo, A. A. Hahalina, K. Yu. Galkina, S. G. Safonova |
| |
| No 1 (2013) |
Adverse drug reactions during treatment of tuberculosis: the main questions |
Abstract
PDF (Rus)
|
|
D. A. Ivanova |
| |
| No 1-2 (2014) |
DRUG-INDUCED LIVER INJURY DURING TREATMENT OF TB PATIENTS |
Abstract
PDF (Rus)
|
|
D. A. Ivanova, M. V. Tityukhina |
| |
| No 1-2 (2014) |
BEDAKVILIN – NEW ANTITUBERCULAR MEDICATION |
Abstract
PDF (Rus)
|
|
S. E. Borisov, D. A. Ivanova |
| |
| 1 - 12 of 12 Items |
|
